Jeff Landau

Jeff Landau currently serves as Chief Business Officer and Head of Strategy at CytomX Therapeutics since April 2021 and holds board positions at California Life Sciences and Sunshine Bio. Landau has extensive experience in business development, corporate strategy, and investment within the life sciences sector, having previously worked at Catalyst Biosciences and Threshold Pharmaceuticals, among others. Educationally, Landau earned an MBA in Health Care Entrepreneurship and Leadership from Stanford University and a BS in Biotechnology/Biochemistry from Virginia Tech, graduating Cum Laude with honors.